Monoclonal antibody 3F8 can effect durable remission in neuroblastoma patients refractory to chemotherapy:a phase II trial.

Bibliographic Information

Other Title
  • Monoclonal antibody 3F8 can effect durable remissions in neuroblastoma patients refractory to chemotherapy: a phase II trial

Journal

Citations (2)*help

See more

Details 詳細情報について

  • CRID
    1573105974055466368
  • NII Article ID
    10004790727
  • Data Source
    • CiNii Articles
    • Crossref

Report a problem

Back to top